Product Overview?
4-(Aminomethyl)benzoic Acid (CAS: 56-91-7) is a white crystalline powder widely utilized as a pharmaceutical intermediate and hemostatic agent. With high purity and stability, it serves critical roles in medical, cosmetic, and agricultural industries. Its primary function lies in inhibiting fibrinolysis, making it effective for controlling excessive bleeding and enhancing formulations in skincare products.

? ?Key Advantages?
? ?Superior Hemostatic Activity?: Demonstrates 4-5x stronger efficacy compared to aminocaproic acid.
? ?High Purity?: ≥99% purity (HPLC/GC tested), ensuring consistency for pharmaceutical applications.
? ?Thermal Stability?: Stable at high temperatures (melting point: 300-350°C), suitable for industrial processing.

?? ?Application Fields?

• ?Pharmaceuticals?: Core component in hemostatic drugs for surgical and trauma-related bleeding control.

• ?Cosmetics?: Key ingredient in skin-brightening and anti-aging formulations due to its fibrinolysis-inhibiting properties.

• ?Agriculture & Veterinary?: Intermediate for animal health products and crop protection agents.

?? ?Quality Assurance?

• Produced in ?GMP-certified facilities? with strict adherence to EP/USP standards.

• Rigorous QC protocols including ?NMR, HPLC, and mass spectrometry? for batch consistency.

• Compliant with safety guidelines outlined in ?MSDS documentation? for handling and storage.

?? ?Market Insights?
As a critical intermediate for tranexamic acid, this compound aligns with the growing demand for antifibrinolytic drugs and advanced cosmetic ingredients. Industry reports highlight its significance in the $3.8B+ hemostatic drug market, driven by rising healthcare needs and innovation in specialty chemicals.